StockNews.com assumed coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Benchmark reissued a “hold” rating on shares of VolitionRx in a research note on Friday, August 16th. View Our Latest Research Report on VolitionRx […]